Lebwohl David

EDGAR CIK 0001810882

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
Officer
EVP, Chief Medical Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($116,404)
-9,557 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/03/2025
01/07/2025
Sell
-9,557 @ $12.18
 ($116,404) 87,666 (-9.83%) Direct